The Ultimate Resource for Pharmaceutical SOPs and Best Practices
To define a robust and structured system for identifying, documenting, investigating, implementing, and tracking Corrective and Preventive Actions (CAPA) arising from deviations, audits, complaints, change controls, or quality failures in the API manufacturing process.
Click to read the full article.
To define a systematic and controlled procedure for initiating, reviewing, evaluating, approving, implementing, and closing change control requests (CCRs) in API manufacturing, ensuring GMP compliance, traceability, and product quality assurance.
Click to read the full article.
To establish a standard procedure for the preparation and review of Product Quality Reviews (PQRs) for all manufactured Active Pharmaceutical Ingredients (APIs), as per cGMP and regulatory requirements, to ensure consistency of the manufacturing process and continual product quality improvement.
Click to read the full article.
To establish a systematic procedure for controlling, issuing, distributing, revising, retrieving, and archiving all GMP-related documents in API manufacturing to ensure document integrity, traceability, and compliance.
Click to read the full article.
To establish a documented system for planning, conducting, documenting, and following up on internal audits within API manufacturing units in order to assess compliance with Good Manufacturing Practices (GMP), internal policies, and regulatory standards.
Click to read the full article.
To define the procedure for conducting periodic Management Reviews of quality metrics within the API manufacturing facility. This ensures the adequacy, suitability, and effectiveness of the Quality Management System (QMS) and promotes continuous improvement.
Click to read the full article.
To establish a structured process for receiving, documenting, evaluating, investigating, and responding to complaints related to Active Pharmaceutical Ingredients (APIs) manufactured by the facility, ensuring compliance with GMP and regulatory expectations.
Click to read the full article.
To define the procedure for evaluating, authorizing, executing, and documenting reprocessing or rework of any Active Pharmaceutical Ingredient (API) batch that does not meet predetermined specifications and ensure it is conducted in accordance with current Good Manufacturing Practices (cGMP) and regulatory guidelines.
Click to read the full article.
To define the procedure for writing, reviewing, approving, issuing, controlling, and revising Standard Operating Procedures (SOPs) for all GMP-related processes in the API manufacturing facility.
Click to read the full article.
To define a systematic approach for conducting Quality Risk Management (QRM) using the Failure Mode and Effects Analysis (FMEA) method in the API manufacturing facility to proactively identify, assess, and mitigate risks that could affect product quality and regulatory compliance.
Click to read the full article.